InvestorsHub Logo
Followers 228
Posts 14844
Boards Moderated 1
Alias Born 03/29/2014

Re: dennisdave post# 430354

Wednesday, 12/29/2021 11:16:25 AM

Wednesday, December 29, 2021 11:16:25 AM

Post# of 717761
This isn’t the same guidance that Lykiri wrote FDA about.

The three pharmas were responding to requests from FDA on their “Benefit Risk” guidance put out in September 2021:
https://www.fda.gov/media/152544/download

…and Lykiri’s letter to FDA concerned the “Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products” guidance from December 2019 found here (and liked above in the board information - I’ll add the link to the previous Benefit-Risk guidance in the section above later today):
https://www.fda.gov/media/133660/download
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News